Efficacy of Oral Appliances on Obstructive Sleep Apnea During Pregnancy (OSApod)
Primary Purpose
Sleep Apnea, Obstructive, Pregnancy Related
Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Somnodent
Sponsored by
About this trial
This is an interventional other trial for Sleep Apnea, Obstructive
Eligibility Criteria
INCLUSION CRITERIA
- Adult women (≥ 18 years old)
- Pregnant women (between14 and 34 weeks)
- Sleep apnea with respiratory disturbance index (RDI) ≥ 5 events/hour
- Snoring or sleep apnea testimony by chamber partner
EXCLUSION CRITERIA
- Severe sleep apnea
- Evidence of a respiratory sleep disorder other than sleep apnea
- Body mass index greater than 40
- Use of medication that could affect breathing or sleep
- Abnormalities of the upper airway (oversized amygdala)
- Severe temporomandibular disorder
- Periodontal problems and untreated caries
- Poor dental hygiene
- Possible retention of OAM (Not enough teeth to retain the OAM in the mouth )
Sites / Locations
- University of Montreal
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Somnodent
Arm Description
SomnoDent is a custom-made oral appliance for the treatment of mild to moderate obstructive sleep apnea. SomnoDent is worn during sleep to provide Continuous Open Airway Therapy by moving the lower jaw slightly forward. This movement tightens the soft tissue and muscles of the upper airway, which prevents obstructive apneas while sleeping.
Outcomes
Primary Outcome Measures
obstructive sleep apnea
Apnea hypopnea index
Secondary Outcome Measures
adherence
A mini-recorder will be use to see how many hours a day the patient wear the appliance.
Full Information
NCT ID
NCT03138291
First Posted
March 15, 2016
Last Updated
May 10, 2018
Sponsor
Université de Montréal
Collaborators
McGill University Health Centre/Research Institute of the McGill University Health Centre
1. Study Identification
Unique Protocol Identification Number
NCT03138291
Brief Title
Efficacy of Oral Appliances on Obstructive Sleep Apnea During Pregnancy
Acronym
OSApod
Official Title
Efficacy of Oral Appliances on Obstructive Sleep Apnea During Pregnancy
Study Type
Interventional
2. Study Status
Record Verification Date
May 2018
Overall Recruitment Status
Unknown status
Study Start Date
June 2016 (Actual)
Primary Completion Date
April 2018 (Actual)
Study Completion Date
December 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Université de Montréal
Collaborators
McGill University Health Centre/Research Institute of the McGill University Health Centre
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Issue: The prevalence and severity of sleep-disordered breathing increases during pregnancy due to weight gain, physiological and hormonal changes. These sleep breathing disorders have a negative impact on perinatal health for both the mother and the child.The optimal treatment of obstructive sleep apnea in pregnancy is unknown. Although CPAP therapy is often the treatment of choice, the mandibular advancement appliance would be an interesting alternative to solve the matter.
Objectives: The main objective of this pilot study is to evaluate the feasibility of mandibular advancement device to treat sleep apnea during the 2nd and 3rd trimesters of pregnancy. Secondary objectives will be tools to plan a future randomized controlled trial to determine the efficacy of this treatment.
Detailed Description
Study design : Intervention Pilot Study uncontrolled experimental cohort
Population: 32 pregnant women with sleep apnea with an apnea - hypopnea index ( AHI ) ≥ 10 events / hr .
Methodology: The mandibular advancement appliance will be used with the chip DentiTracs to measure adhesion. Participation in this project requires five visits to the research team, including 3 visits at home. Participants will be recruited and granted in obstetrics MUHC. The questionnaires will be filled (Epworth Sleepiness Scale, Pittsburgh sleep quality and functional (FOSQ)). A sleep recording (PSG type II) will be done at home to confirm the diagnosis. The recording equipment will be returned to the research team by mail. During the second visit (clinical orthodontics), dental impressions in alginate will be made. At the 3rd visit (clinical orthodontics), the mandibular advancement appliance will be adjusted and instructions will be given. A weekly phone call follow-up will be ensured during this period of adjustment of the appliance. The fourth visit (at home) will consist of a sleep recording to evaluate the effect of treatment. A questionnaire comfort / secondary effects will be administered. For patients who have started their participation during their second trimester, a sleep recording at home (4a visit) will be realized in Q3 to assess whether it is necessary to change the titration of the appliance. The 5th visit (orthodontic clinic) will be 3-6 months after delivery. Participants will fulfill all the mentioned questionnaires and make a sleep recording at home without the appliance. Replace the appliance in place if AHI> 10. During the 4th and 5th visits, anthropometric data (ie, weight), and objective adhesion will be taken
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Apnea, Obstructive, Pregnancy Related
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
17 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Somnodent
Arm Type
Experimental
Arm Description
SomnoDent is a custom-made oral appliance for the treatment of mild to moderate obstructive sleep apnea. SomnoDent is worn during sleep to provide Continuous Open Airway Therapy by moving the lower jaw slightly forward. This movement tightens the soft tissue and muscles of the upper airway, which prevents obstructive apneas while sleeping.
Intervention Type
Device
Intervention Name(s)
Somnodent
Intervention Description
Each pregnant women will be treat with a Somnodent
Primary Outcome Measure Information:
Title
obstructive sleep apnea
Description
Apnea hypopnea index
Time Frame
9 months
Secondary Outcome Measure Information:
Title
adherence
Description
A mini-recorder will be use to see how many hours a day the patient wear the appliance.
Time Frame
9 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
INCLUSION CRITERIA
Adult women (≥ 18 years old)
Pregnant women (between14 and 34 weeks)
Sleep apnea with respiratory disturbance index (RDI) ≥ 5 events/hour
Snoring or sleep apnea testimony by chamber partner
EXCLUSION CRITERIA
Severe sleep apnea
Evidence of a respiratory sleep disorder other than sleep apnea
Body mass index greater than 40
Use of medication that could affect breathing or sleep
Abnormalities of the upper airway (oversized amygdala)
Severe temporomandibular disorder
Periodontal problems and untreated caries
Poor dental hygiene
Possible retention of OAM (Not enough teeth to retain the OAM in the mouth )
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sushmita Pamidi, MD
Organizational Affiliation
McGill University
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Montreal
City
Montreal
State/Province
Quebec
ZIP/Postal Code
h3v 1h9
Country
Canada
12. IPD Sharing Statement
Plan to Share IPD
Yes
Citations:
PubMed Identifier
35829947
Citation
Huynh N, Drouin-Gagne L, Gilbert C, Arcache JP, Rompre P, Morency AM, Gagnon R, Kimoff J, Pamidi S. Adherence and efficacy of mandibular advancement splint treatment of sleep-disordered breathing during pregnancy: a pilot study. Sleep Breath. 2023 Jun;27(3):869-877. doi: 10.1007/s11325-022-02681-4. Epub 2022 Jul 13.
Results Reference
derived
Learn more about this trial
Efficacy of Oral Appliances on Obstructive Sleep Apnea During Pregnancy
We'll reach out to this number within 24 hrs